RxDoctor Payments Data

Melissa Polk, OD

Optometrist · El Dorado, ARNPI 1992431597

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,947 of the $4,546 with a category attached, or 64.8%. 16 manufacturers reported payments, led by Biotissue Holdings Inc. at 44.1% of the total. Reporting peaked in 2023 at $2,773 and has fallen 74.6% since, to $705 in 2025. Among optometrist clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,546in general payments, 2019–2025

Across 68 payments — averaging $66.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$2K
  • Alcon$440
  • Tarsus Pharmaceuticals, Inc.$383
  • Glaukos Corporation$340
  • Johnson & Johnson Vision Care, Inc.$264
  • Dompe US, Inc.$174
  • plus $943 from 10 others

What the payments were for

  • Travel & lodging$1,52133%
  • Food & beverage$2,94765%
  • Entertainment$782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,546 in reported general payments places this provider in the 95th percentile of 442 optometrist providers in Arkansas.

See all optometrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$25,479
Medicare patients
97
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost14$197

Paid to pharmacies, not to this prescriber.

Other optometrist in El Dorado

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →